Overview

Topical Use of Corticosteroid to Prevent Epiretinal Membrane Following Retinal Tear

Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
In this prospective randomized controlled double blind pilot clinical study, we aim to assess whether administration of a topical corticosteroid would attenuate epiretinal membrane formation following development of retinal tears treated with laser retionpexy.
Phase:
N/A
Details
Lead Sponsor:
St. Michael's Hospital, Toronto
Unity Health Toronto
Collaborator:
University of Toronto
Treatments:
Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate